Page last updated: 2024-09-04

moxifloxacin and Bradycardia

moxifloxacin has been researched along with Bradycardia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eusebio, J; Farhoumand, AD; Trombert, V	1
Absi, M; Ghareeb, H; Khalil, A; Ruegg, UT	1
Akyurek, O; Altin, T; Guldal, M; Karaoguz, R; Ongun Ozdemir, A; Ozcan, O; Turhan, S	1
Delesen, H; Kubitza, D; Rink, AD; Stass, H; Vestweber, KH	1

Trials

1 trial(s) available for moxifloxacin and Bradycardia

Article	Year
Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess. Clinical drug investigation, 2008, Volume: 28, Issue:2 Topics: Abdominal Abscess; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Infective Agents; Area Under Curve; Aza Compounds; Body Fluids; Bradycardia; Drainage; Female; Fluoroquinolones; Half-Life; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Moxifloxacin; Quinolines; Time Factors; Tissue Distribution; Tomography, X-Ray Computed	2008

Article

Year

Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess.

Clinical drug investigation, 2008, Volume: 28, Issue:2

Topics: Abdominal Abscess; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Infective Agents; Area Under Curve; Aza Compounds; Body Fluids; Bradycardia; Drainage; Female; Fluoroquinolones; Half-Life; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Moxifloxacin; Quinolines; Time Factors; Tissue Distribution; Tomography, X-Ray Computed

2008

Other Studies

3 other study(ies) available for moxifloxacin and Bradycardia

Article	Year
[Practical ECG problems in the elderly patient. Case number 16. Moxifloxacin-associated QT interval prolongation]. Revue medicale suisse, 2011, Mar-16, Volume: 7, Issue:286 Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Anti-Infective Agents; Atenolol; Aza Compounds; Bradycardia; Electrocardiography; Female; Fluoroquinolones; Humans; Long QT Syndrome; Moxifloxacin; Quinolines	2011
The effect of levofloxacin and moxifloxacin on cardiovascular functions of rats with streptozotocin-induced diabetes. Diabetes & vascular disease research, 2013, Volume: 10, Issue:1 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Biological Factors; Blood Glucose; Bradycardia; Cardiovascular System; Diabetes Mellitus, Experimental; Electrocardiography; Endothelium, Vascular; Fluoroquinolones; Heart; Heart Rate; Hypoglycemia; Intermediate-Conductance Calcium-Activated Potassium Channels; Levofloxacin; Male; Mesenteric Arteries; Moxifloxacin; Ofloxacin; Quinolines; Rats; Rats, Wistar; Small-Conductance Calcium-Activated Potassium Channels; Streptozocin	2013
Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event. The Canadian journal of cardiology, 2007, Volume: 23, Issue:11 Topics: Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Bradycardia; Cardiac Pacing, Artificial; Female; Fluoroquinolones; Humans; Long QT Syndrome; Moxifloxacin; Pneumonia; Quinolines; Risk Factors; Syncope; Torsades de Pointes; Treatment Outcome	2007